143 related articles for article (PubMed ID: 37713930)
1. Association between post-operative hPG
Doucet L; Cailleteau A; Vaugier L; Gourmelon C; Bureau M; Salaud C; Roualdes V; Samarut E; Aumont M; Zenatri M; Loussouarn D; Quillien V; Bocquet F; Payen-Gay L; Joubert D; Prieur A; Robert M; Frenel JS
ESMO Open; 2023 Oct; 8(5):101626. PubMed ID: 37713930
[TBL] [Abstract][Full Text] [Related]
2. Plasma hPG
Dupuy M; Iltache S; Rivière B; Prieur A; Pageaux GP; Bedoya JU; Faure S; Guillaumée H; Assenat E
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053564
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Plasma hPG
Kohli M; Tan W; Vire B; Liaud P; Blairvacq M; Berthier F; Rouison D; Garnier G; Payen L; Cousin T; Joubert D; Prieur A
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498444
[TBL] [Abstract][Full Text] [Related]
4. Plasma hPG
Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
[TBL] [Abstract][Full Text] [Related]
5. A novel method to detect hPG
Cappellini M; Flaceliere M; Saywell V; Soule J; Blanc E; Belouin F; Ortiz E; Canterel-Thouennon L; Poupeau S; Tigrett S; Vire B; Liaud P; Blairvacq M; Joubert D; Prieur A
Anal Methods; 2021 Oct; 13(38):4468-4477. PubMed ID: 34494619
[TBL] [Abstract][Full Text] [Related]
6. hPG
Chauhan A; Prieur A; Kolesar J; Arnold S; Payen L; Mahi Y; Vire B; Sands M; Evers BM; Joubert D; Anthony L
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205614
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.
You B; Mercier F; Assenat E; Langlois-Jacques C; Glehen O; Soulé J; Payen L; Kepenekian V; Dupuy M; Belouin F; Morency E; Saywell V; Flacelière M; Elies P; Liaud P; Mazard T; Maucort-Boulch D; Tan W; Vire B; Villeneuve L; Ychou M; Kohli M; Joubert D; Prieur A
EBioMedicine; 2020 Jan; 51():102574. PubMed ID: 31877416
[TBL] [Abstract][Full Text] [Related]
8. [hPG
You B; Assenat E; Payen L; Mazard T; Glehen O; Calattini S; Villeneuve L; Lescuyer G; Vire B; Ychou M
Bull Cancer; 2022 Jun; 109(6):707-713. PubMed ID: 35597620
[TBL] [Abstract][Full Text] [Related]
9. hPG
Casile M; Passildas J; Vire B; Molnar I; Durando X
Front Neurol; 2022; 13():1073476. PubMed ID: 36712425
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P
PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894
[TBL] [Abstract][Full Text] [Related]
11. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
[TBL] [Abstract][Full Text] [Related]
12. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.
Marini A; Dobran M; Aiudi D; Pesaresi A; di Somma LGM; Iacoangeli M
Clin Neurol Neurosurg; 2020 Oct; 197():106162. PubMed ID: 32890893
[TBL] [Abstract][Full Text] [Related]
17. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
Cheng X; Lou S; Huang S; Chen H; Liu J
World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
[TBL] [Abstract][Full Text] [Related]
18. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
20. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
